Alan Talevi

Boulevard 120 1490
La Plata, B, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Comparative study of lipidic and polymeric nanoparticles encapsulating benznidazole in an acute mice model of Chagas disease.

Comparative study of lipidic and polymeric nanoparticles encapsulating benznidazole in an acute mice model of Chagas disease.

Journal: Acta tropica

Published: March 20, 2026

Comparative study of lipidic and polymeric nanoparticles encapsulating Benznidazole in an acute mice model of Chagas disease.

Comparative study of lipidic and polymeric nanoparticles encapsulating Benznidazole in an acute mice model of Chagas disease.

Journal: Acta tropica

Published: March 20, 2026

Drug Repurposing Against Cestode Fatty Acid Binding Proteins Through Integrated Virtual Screening and In Vitro Validation.

Drug Repurposing Against Cestode Fatty Acid Binding Proteins Through Integrated Virtual Screening and In Vitro Validation.

Journal: ChemMedChem

Published: March 07, 2026

Lipid Nanoparticles with Stiripentol and Cannabidiol Oil: From Rational Optimization to Preclinical Characterization.

Lipid Nanoparticles with Stiripentol and Cannabidiol Oil: From Rational Optimization to Preclinical Characterization.

Journal: Pharmaceutics

Published: March 07, 2026

Advancing AI-driven drug discovery: an interview with Professor Alan Talevi.

Advancing AI-driven drug discovery: an interview with Professor Alan Talevi.

Journal: Expert opinion on drug discovery

Published: March 02, 2026

Computer-Aided Discovery of Drugs Against Chagas Disease.

Computer-Aided Discovery of Drugs Against Chagas Disease.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: November 03, 2025

Application of Data-Centric Supervised Machine Learning to Predict Phenotypic Activity Against Clinically Relevant Stages of Trypanosoma cruzi.

Application of Data-Centric Supervised Machine Learning to Predict Phenotypic Activity Against Clinically Relevant Stages of Trypanosoma cruzi.

Journal: Pharmaceutics

Published: October 12, 2025

Tackling the issue of confined chemical space with AI-based de novo drug design and molecular optimization.

Tackling the issue of confined chemical space with AI-based de novo drug design and molecular optimization.

Journal: Expert opinion on drug discovery

Published: August 31, 2025

Advancing Trypanosoma cruzi N-myristoyltransferase as a drug target for Chagas disease through in silico discovery and biochemical evaluation.

Advancing Trypanosoma cruzi N-myristoyltransferase as a drug target for Chagas disease through in silico discovery and biochemical evaluation.

Journal: Frontiers in molecular biosciences

Published: July 15, 2025

Cannabidiol combined with GABAergic drugs but not with sodium channel blockers prevents the development of drug-resistance seizures in a preclinical model.

Cannabidiol combined with GABAergic drugs but not with sodium channel blockers prevents the development of drug-resistance seizures in a preclinical model.

Journal: Frontiers in pharmacology

Published: June 26, 2025

Discovery of Trypanosoma cruzi Carbonic Anhydrase Inhibitors by a Combination of Ligand- and Structure-Based Virtual Screening.

Discovery of Trypanosoma cruzi Carbonic Anhydrase Inhibitors by a Combination of Ligand- and Structure-Based Virtual Screening.

Journal: Journal of chemical information and modeling

Published: May 12, 2025

Mitigation of Acute Seizures and Neuropathology after Traumatic Brain Injury by Structure-Based Discovery-Identified Drugs.

Mitigation of Acute Seizures and Neuropathology after Traumatic Brain Injury by Structure-Based Discovery-Identified Drugs.

Journal: Journal of neurotrauma

Published: April 17, 2025

Showing 1-12 of 87

Last Updated: 09/26/2026